Vascular Grafts Market Sales to Exceed 8.5 Billion by 2030

The global vascular grafts market is on the rise. According to research and consulting company, Precedence Research, the market size of vascular grafts worldwide will hit US$ 8.5 billion by 2030, up from US$ 5.65 billion in 2022. This means a cumulative average growth rate (CAGR) of 5.24% from 2022 to 2030. The report contains 150+ pages with detailed analysis.

The vascular graft market shows a tremendous growth owing to the increase in the number of minimally invasive procedures carried out by the technically advanced hospitals and healthcare systems. This minimally invasive procedure has become a major part of many surgical procedures related to the vital organs in the human body.

Vascular Grafts Market Report Scope

Download a FREE Sample Copy (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1758

Vascular Grafts Market Report Highlights

• On the basis of the product, the endovascular stent grafts segment is expected to dominate the market in the forecast period. The developments in the endovascular applications will lead to a growth in the endovascular stent grafts market.
• The cardiac aneurysm segment will grow during the forecast period as the congenital heart disease and other congenital heart surgeries which are carried out using the advanced tissue engineered grafts is in demand and the demand shall grow.
• On the basis of the raw material used, the polytetrafluoroethylene segment is expected to grow during the forecast period, it is used for the peripheral bypass procedures as this material adequately interacts with the tissue and it is extremely easy to use.

Regional Snapshots

The region of North America is considered to be the largest ground for the development of this market. Owing to the rising health care awareness, availability of facilities, high number of people living in this developed country, high availability of reimbursement and the shift to advanced procedures are helping the market to grow. However, the region of Asia Pacific has also shown a tremendous growth during the forecast.

This region is seen to have a high number of patients suffering with cardiovascular diseases, kidney problems and diabetes which helped to fuel this market to a great extent. The other regions which help in the growth of this market are Europe and Russia which also have a great number of cases with cardiovascular diseases and renal disorders.

Vascular Grafts Market Dynamics

Drivers

The factors driving this market includes the high number of chronic kidney diseases amongst the people, the increase in the number of dialysis that take place, the high rate of diabetic individuals. Moreover, the existence of cardiovascular diseases and renal disorders has helped to grow the market to a great extent.

The adoption of minimally invasive procedures carried out by the advanced healthcare system has also increased the demand for vascular graft market over the period of time. This also helps in better healing of wounds and further reduces the complications that the patient has to undergo. The reduction in neointimal formation followed after complex vascular surgeries have shown a tremendous growth in the market during the forecast.

Restraints

The outbreak of the pandemic led to a decline in the market growth of the vascular grafts due to the interruption in the operation procedures and supply chains. As a result of the pandemic only essential services were carried out and non essential surgeries and procedures were neglected. Elective procedures had become the fashion of the ongoing market.

During the pandemic the vascular and cardiac operative procedures witnessed a 8.5% decrease worldwide. Moreover, the increase in the total cost of the vascular graft procedures also hinders the growth of the market during the forecast. The developed nations opt for these services whereas the developing and underdeveloped nations face a challenge to cope with the increasing cost.

Also Read: Nanomaterials Market Sales to Exceed 43.1 Billion by 2030

Opportunities

The increase in the minimally invasive procedures which are required for chronic heart diseases and renal diseases has provided a great opportunity for the growth of the vascular graft market. The reduced side effects and complications faced by the patients has helped the market to grow. The peripheral vascular market is another segment which shows tremendous growth due to the increased number of renal disorder and arterial diseases. All these factors provide a great opportunity to the vascular graft market during the forecast.

Challenges

The failure of a vascular graft can have severe adverse effects on the health of consumers. Malfunction of vascular grafts can cause a risk to the life of the consumer and hence the adoption of the new advanced technology will be hampered to a great extent which can affect the growth of the market in the forecast period.

The higher cost associated with these kind of graphs also creates a great challenge for the developing market. Failure of a vascular graft also leads to an additional expense in which an operation has to be done again. All these factors proved to be a great challenge for the growth of the vascular graft market.

Recent Developments

• Medtronic has obtained approval for ll/lls, Thoracic stent which is used along with Heli-FX EndoAnchor.
• In 2017, Endologix Inc has made an agreement with Deerfield management which is a healthcare organization. A funding worth $170 million has been granted to it.

Vascular Grafts Market Key Players

• Getinge AB
• Medtronic PLC
• LeMaitre vascular Inc
• WL gore and associates
• terumo corporation
• Shanghai suokang medical implants Co limited
• Cook medical

Segments Covered in the report

By Product

• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts
• Endovascular Stent Grafts
• Coronary Artery By-Pass Grafts

By Application

• Cardiac Aneurysm
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease

By Raw Material

• Polyester Vascular Grafts
• Polytetrafluoroethylene Vascular Grafts
• Polyurethane Vascular Grafts
• Biological Material Based Vascular Grafts
  • Human Saphenous and Umbilical Veins
  • Tissue Engineered Materials

By End User

• Hospitals
• Ambulatory Surgical Centers

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Philippines
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC
  • North Africa
  • South Africa
  • Rest of the Middle East & Africa

Research Methodology

A unique research methodology has been utilized to conduct comprehensive research on the growth of the global vascular grafts market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions.

Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global vascular grafts market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimate the future prospects of the global market more reliable and accurately.

Why should you invest in this report?

If you are aiming to enter the global vascular grafts market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for vascular grafts are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Vascular Grafts Market 

5.1. COVID-19 Landscape: Vascular Grafts Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Vascular Grafts Market, By Product

8.1. Vascular Grafts Market, by Product Type, 2022-2030

8.1.1. Vascular Grafts for Aorta Disease

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Peripheral Vascular Grafts

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Endovascular Stent Grafts

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Coronary Artery By-Pass Grafts

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Vascular Grafts Market, By End Use

9.1. Vascular Grafts Market, by End Use, 2022-2030

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Ambulatory Surgical Centers

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Vascular Grafts Market, By Application Type 

10.1. Vascular Grafts Market, by Application Type, 2022-2030

10.1.1. Cardiac Aneurysm

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Kidney Failure

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Vascular Occlusion

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Coronary Artery Disease

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Vascular Grafts Market, By Raw Material Type 

11.1. Vascular Grafts Market, by Raw Material Type, 2022-2030

11.1.1. Polyester Vascular Grafts

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Polytetrafluoroethylene Vascular Grafts

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Polyurethane Vascular Grafts

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Biological Material Based Vascular Grafts

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Human Saphenous and Umbilical Veins

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Tissue Engineered Materials

11.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Vascular Grafts Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by End Use (2017-2030)

12.1.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.1.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

Chapter 13. Company Profiles

13.1. Getinge AB

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Medtronic PLC

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. L犀利士
eMaitre vascular Inc

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. WL gore and associates

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. terumo corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Shanghai suokang medical implants Co limited

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Cook Medical

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1758

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com